Levothyroxine Sodium Tablet
Product Images NDC 51655-989

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-989). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (449d2ef9 3580 46c8 8fe5 5d81cb18e40f 01)

FDA Label Image

Label (51655 989 52 Master Bottle Label Approval Rev A 05 22)

Label (51655 989 52 Master Bottle Label Approval   Rev A 05 22)
NDC 51655-989-52 is a prescription medication containing 30 tablets of Levothyroxine Sodium Tablets, USP with a strength of 75 meg (0.075mg). This medication is used to treat an underactive thyroid. The tablets should be stored at temperatures between 25°C (77°F) to 30°C (86°F) and should be kept away from children. This medication should be stored in its original container and protected from light and moisture. This product is repackaged by Northwind Pharmaceuticals and is made by Lupin Pharmaceuticals. The lot number is 0000000000 with an expiration date of 00/00/0000.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.